Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.

Laura C Maclagan Naomi P VisanjiYi ChengMina TadrousAlix M B LacosteLorraine V KaliaSusan E BronskillConnie Marras

Published in: Pharmacoepidemiology and drug safety (2020)

Our findings demonstrate the feasibility of this approach to focus the search for disease-modifying drugs. Corticosteroids and methylxanthines should be further investigated as potential disease-modifyingdrugs in PD.

Keyphrases

artificial intelligence
machine learning
big data
deep learning
human health
mass spectrometry
climate change
high resolution